EuBiologics Co., Ltd. (KOSDAQ:206650)
South Korea · Delayed Price · Currency is KRW 7,950.00
+10.00 (0.13%)
Nov 4, 2026, 3:30 PM KST
EuBiologics Market Cap
EuBiologics has a market cap or net worth of 292.18 billion as of November 3, 2026. It is the 20,123rd most valuable company in the world and the 621st biggest in South Korea. Its market cap has decreased by 35.08% in one year.
Market Cap
292.18B
Enterprise Value
n/a
Revenue
96.04B
Global Rank
Country Rank
#621 South Korea
PE Ratio
11.50
ChartMarket Cap Chart
Since January 24, 2017, EuBiologics's market cap has increased from 122.86B to 292.18B, an increase of 137.82%. That is a compound annual growth rate of 9.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 292.18B | -29.86% |
| Dec 30, 2025 | 416.60B | -6.15% |
| Dec 30, 2024 | 443.89B | 6.16% |
| Dec 28, 2023 | 418.14B | 28.91% |
| Dec 29, 2022 | 324.36B | -74.49% |
| Dec 30, 2021 | 1.27T | 93.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ildong Pharmaceutical | 397.63B |
| Bukwang Pharmaceutical | 366.05B |
| HLB Pharmaceutical | 354.23B |
| Dong-A ST | 339.28B |
| JW Holdings | 270.88B |
| Samjin Pharmaceuticals | 237.80B |
| Humedix | 231.17B |
| Korea United Pharm | 230.21B |